We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
DHI Group Inc | NYSE:DHX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.01 | -0.39% | 2.54 | 2.63 | 2.52 | 2.60 | 171,044 | 01:00:00 |
|
|
|
|
|
R
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
£
|
TRANSITION PERIOD PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
20-3179218
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
1040 Avenue of the Americas, 8
th
Floor
|
|
|
New York, New York
|
|
10018
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
|
|
|
|
|
Page
|
PART I.
|
FINANCIAL INFORMATION
|
|
|
Item 1.
|
Unaudited
Financial Statements
|
|
|
|
Condensed Consolidated Balance Sheets as of September 30, 2017 and December 31, 2016
|
|
|
|
Condensed Consolidated Statements of Operations for the three and nine month periods ended September 30, 2017 and 2016
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and nine month periods ended September 30, 2017 and 2016
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the nine month periods ended September 30, 2017 and 2016
|
|
|
|
Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
|
|
Item 2.
|
|
||
|
|
|
|
Item 3.
|
|
||
|
|
|
|
Item 4.
|
|
||
|
|
|
|
PART II.
|
OTHER INFORMATION
|
|
|
Item 1.
|
|
||
|
|
|
|
Item 1A.
|
|
||
|
|
|
|
Item 2.
|
|
||
|
|
|
|
Item 5.
|
|
||
|
|
|
|
Item 6.
|
|
||
|
|
|
|
SIGNATURES
|
|
|
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
September 30,
2017 |
|
December 31, 2016
|
||||
ASSETS
|
|
|
|
||||
Current assets
|
|
|
|
||||
Cash
|
$
|
22,086
|
|
|
$
|
22,987
|
|
Accounts receivable, net of allowance for doubtful accounts of $1,769 and $3,181
|
33,146
|
|
|
43,148
|
|
||
Income taxes receivable
|
2,141
|
|
|
731
|
|
||
Prepaid and other current assets
|
4,482
|
|
|
3,312
|
|
||
Total current assets
|
61,855
|
|
|
70,178
|
|
||
Fixed assets, net
|
17,119
|
|
|
16,610
|
|
||
Acquired intangible assets, net
|
47,440
|
|
|
49,120
|
|
||
Goodwill
|
176,641
|
|
|
171,745
|
|
||
Deferred income taxes
|
365
|
|
|
306
|
|
||
Other assets
|
2,584
|
|
|
2,136
|
|
||
Total assets
|
$
|
306,004
|
|
|
$
|
310,095
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
Current liabilities
|
|
|
|
||||
Accounts payable and accrued expenses
|
$
|
20,572
|
|
|
$
|
20,220
|
|
Deferred revenue
|
81,823
|
|
|
84,615
|
|
||
Income taxes payable
|
1,302
|
|
|
3,467
|
|
||
Total current liabilities
|
103,697
|
|
|
108,302
|
|
||
Long-term debt, net
|
68,402
|
|
|
84,760
|
|
||
Deferred income taxes
|
7,909
|
|
|
7,901
|
|
||
Accrual for unrecognized tax benefits
|
4,871
|
|
|
2,513
|
|
||
Other long-term liabilities
|
2,809
|
|
|
2,736
|
|
||
Total liabilities
|
187,688
|
|
|
206,212
|
|
||
Commitments and contingencies (Note 7)
|
|
|
|
||||
Stockholders’ equity
|
|
|
|
||||
Convertible preferred stock, $.01 par value, authorized 20,000 shares; no shares issued and outstanding
|
—
|
|
|
—
|
|
||
Common stock, $.01 par value, authorized 240,000; issued 82,880 and 81,989 shares, respectively; outstanding: 50,265 and 49,591 shares, respectively
|
829
|
|
|
820
|
|
||
Additional paid-in capital
|
373,203
|
|
|
366,247
|
|
||
Accumulated other comprehensive loss
|
(27,623
|
)
|
|
(32,276
|
)
|
||
Accumulated earnings
|
48,018
|
|
|
44,078
|
|
||
Treasury stock, 32,615 and 32,398 shares, respectively
|
(276,111
|
)
|
|
(274,986
|
)
|
||
Total stockholders’ equity
|
118,316
|
|
|
103,883
|
|
||
Total liabilities and stockholders’ equity
|
$
|
306,004
|
|
|
$
|
310,095
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Revenues
|
$
|
52,424
|
|
|
$
|
56,073
|
|
|
$
|
157,014
|
|
|
$
|
172,032
|
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Cost of revenues
|
7,616
|
|
|
7,943
|
|
|
22,681
|
|
|
24,557
|
|
||||
Product development
|
6,423
|
|
|
6,018
|
|
|
19,230
|
|
|
19,323
|
|
||||
Sales and marketing
|
19,988
|
|
|
19,425
|
|
|
59,638
|
|
|
58,573
|
|
||||
General and administrative
|
9,454
|
|
|
10,101
|
|
|
30,779
|
|
|
32,822
|
|
||||
Depreciation
|
2,576
|
|
|
2,478
|
|
|
7,703
|
|
|
7,639
|
|
||||
Amortization of intangible assets
|
554
|
|
|
1,570
|
|
|
1,686
|
|
|
6,106
|
|
||||
Impairment of goodwill
|
—
|
|
|
15,369
|
|
|
—
|
|
|
15,369
|
|
||||
Impairment of fixed and intangible assets
|
2,226
|
|
|
9,252
|
|
|
2,226
|
|
|
9,252
|
|
||||
Disposition related and other costs (Note 9)
|
1,049
|
|
|
—
|
|
|
2,236
|
|
|
3,347
|
|
||||
Total operating expenses
|
49,886
|
|
|
72,156
|
|
|
146,179
|
|
|
176,988
|
|
||||
Operating income (loss)
|
2,538
|
|
|
(16,083
|
)
|
|
10,835
|
|
|
(4,956
|
)
|
||||
Interest expense
|
(1,173
|
)
|
|
(901
|
)
|
|
(2,777
|
)
|
|
(2,593
|
)
|
||||
Other expense
|
(3
|
)
|
|
(1
|
)
|
|
(10
|
)
|
|
(33
|
)
|
||||
Income (loss) before income taxes
|
1,362
|
|
|
(16,985
|
)
|
|
8,048
|
|
|
(7,582
|
)
|
||||
Income tax (benefit) expense
|
304
|
|
|
(144
|
)
|
|
3,828
|
|
|
3,294
|
|
||||
Net income (loss)
|
$
|
1,058
|
|
|
$
|
(16,841
|
)
|
|
$
|
4,220
|
|
|
$
|
(10,876
|
)
|
|
|
|
|
|
|
|
|
||||||||
Basic earnings (loss) per share
|
$
|
0.02
|
|
|
$
|
(0.35
|
)
|
|
$
|
0.09
|
|
|
$
|
(0.22
|
)
|
Diluted earnings (loss) per share
|
$
|
0.02
|
|
|
$
|
(0.35
|
)
|
|
$
|
0.09
|
|
|
$
|
(0.22
|
)
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average basic shares outstanding
|
48,021
|
|
|
47,719
|
|
|
47,858
|
|
|
48,596
|
|
||||
Weighted-average diluted shares outstanding
|
48,502
|
|
|
47,719
|
|
|
48,397
|
|
|
48,596
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Net income (loss)
|
$
|
1,058
|
|
|
$
|
(16,841
|
)
|
|
$
|
4,220
|
|
|
$
|
(10,876
|
)
|
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustment
|
1,782
|
|
|
(2,221
|
)
|
|
4,653
|
|
|
(8,857
|
)
|
||||
Total other comprehensive income (loss)
|
1,782
|
|
|
(2,221
|
)
|
|
4,653
|
|
|
(8,857
|
)
|
||||
Comprehensive income (loss)
|
$
|
2,840
|
|
|
$
|
(19,062
|
)
|
|
$
|
8,873
|
|
|
$
|
(19,733
|
)
|
|
Nine Months Ended September 30,
|
||||||
|
2017
|
|
2016
|
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income (loss)
|
4,220
|
|
|
(10,876
|
)
|
||
Adjustments to reconcile net income to net cash flows from operating activities:
|
|
|
|
||||
Depreciation
|
7,703
|
|
|
7,639
|
|
||
Amortization of intangible assets
|
1,686
|
|
|
6,106
|
|
||
Deferred income taxes
|
(23
|
)
|
|
(1,977
|
)
|
||
Amortization of deferred financing costs
|
642
|
|
|
243
|
|
||
Stock based compensation
|
6,275
|
|
|
8,750
|
|
||
Impairment of goodwill
|
—
|
|
|
15,369
|
|
||
Impairment of fixed and intangible assets
|
2,226
|
|
|
9,252
|
|
||
Change in accrual for unrecognized tax benefits
|
2,358
|
|
|
166
|
|
||
Loss on sale of business
|
—
|
|
|
639
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
10,607
|
|
|
8,047
|
|
||
Prepaid expenses and other assets
|
(1,041
|
)
|
|
(618
|
)
|
||
Accounts payable and accrued expenses
|
(152
|
)
|
|
(3,430
|
)
|
||
Income taxes receivable/payable
|
(3,599
|
)
|
|
(1,682
|
)
|
||
Deferred revenue
|
(3,774
|
)
|
|
(493
|
)
|
||
Other, net
|
51
|
|
|
(123
|
)
|
||
Net cash flows from operating activities
|
27,179
|
|
|
37,012
|
|
||
Cash flows used in investing activities:
|
|
|
|
||||
Cash received from sale of business
|
—
|
|
|
2,429
|
|
||
Purchases of fixed assets
|
(10,160
|
)
|
|
(8,461
|
)
|
||
Purchase of cost method investments
|
(500
|
)
|
|
—
|
|
||
Net cash flows used in investing activities
|
(10,660
|
)
|
|
(6,032
|
)
|
||
Cash flows used in financing activities:
|
|
|
|
||||
Payments on long-term debt
|
(17,000
|
)
|
|
(26,000
|
)
|
||
Proceeds from long-term debt
|
—
|
|
|
17,000
|
|
||
Payments under stock repurchase plan
|
—
|
|
|
(26,179
|
)
|
||
Proceeds from stock option exercises
|
403
|
|
|
2,664
|
|
||
Purchase of treasury stock related to vested restricted stock and performance stock units
|
(1,125
|
)
|
|
(2,779
|
)
|
||
Net cash flows used in financing activities
|
(17,722
|
)
|
|
(35,294
|
)
|
||
Effect of exchange rate changes
|
302
|
|
|
(315
|
)
|
||
Net change in cash for the period
|
(901
|
)
|
|
(4,629
|
)
|
||
Cash, beginning of period
|
22,987
|
|
|
34,050
|
|
||
Cash, end of period
|
$
|
22,086
|
|
|
$
|
29,421
|
|
|
|
|
|
•
|
Level 1 – Quoted prices for identical instruments in active markets.
|
•
|
Level 2 – Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations, in which all significant inputs are observable in active markets.
|
•
|
Level 3 – Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
|
|
As of September 30, 2017
|
||||||||||||||
|
Total Cost
|
|
Accumulated
Amortization
|
|
Foreign
Currency
Translation
Adjustment
|
|
Acquired
Intangible
Assets, Net
|
||||||||
Technology
|
$
|
5,228
|
|
|
$
|
(4,597
|
)
|
|
$
|
(631
|
)
|
|
$
|
—
|
|
Trademarks and brand names—Dice
|
39,000
|
|
|
—
|
|
|
—
|
|
|
39,000
|
|
||||
Trademarks and brand names—Other
|
13,394
|
|
|
(8,436
|
)
|
|
(2,185
|
)
|
|
2,773
|
|
||||
Customer lists
|
14,500
|
|
|
(6,721
|
)
|
|
(2,112
|
)
|
|
5,667
|
|
||||
Candidate and content database
|
8,857
|
|
|
(8,354
|
)
|
|
(503
|
)
|
|
—
|
|
||||
Acquired intangible assets, net
|
$
|
80,979
|
|
|
$
|
(28,108
|
)
|
|
$
|
(5,431
|
)
|
|
$
|
47,440
|
|
|
As of December 31, 2016
|
||||||||||||||||||
|
Total Cost
|
|
Accumulated
Amortization
|
|
Foreign
Currency
Translation
Adjustment
|
|
Impairment
|
|
Acquired
Intangible
Assets, Net
|
||||||||||
Technology
|
$
|
10,308
|
|
|
$
|
(9,677
|
)
|
|
$
|
(631
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
Trademarks and brand names—Dice
|
39,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
39,000
|
|
|||||
Trademarks and brand names—Other
|
23,194
|
|
|
(14,379
|
)
|
|
(2,286
|
)
|
|
(3,168
|
)
|
|
3,361
|
|
|||||
Customer lists
|
28,473
|
|
|
(13,518
|
)
|
|
(2,112
|
)
|
|
(6,084
|
)
|
|
6,759
|
|
|||||
Candidate and content database
|
15,918
|
|
|
(15,295
|
)
|
|
(623
|
)
|
|
—
|
|
|
—
|
|
|||||
Acquired intangible assets, net
|
$
|
116,893
|
|
|
$
|
(52,869
|
)
|
|
$
|
(5,652
|
)
|
|
$
|
(9,252
|
)
|
|
$
|
49,120
|
|
October 1, 2017 through December 31, 2017
|
$
|
507
|
|
2018
|
1,781
|
|
|
2019
|
1,476
|
|
|
2020
|
1,421
|
|
|
2021
|
1,149
|
|
|
2022 and thereafter
|
2,106
|
|
|
Total
|
$
|
8,440
|
|
|
September 30,
2017 |
|
December 31,
2016 |
||||
Amounts borrowed:
|
|
|
|
||||
Revolving credit facility
|
$
|
69,000
|
|
|
$
|
86,000
|
|
Less: deferred financing costs, net of accumulated amortization of $1,480 and $1,487
|
(598
|
)
|
|
(1,240
|
)
|
||
Total borrowed
|
$
|
68,402
|
|
|
$
|
84,760
|
|
|
|
|
|
||||
Available to be borrowed under revolving facility, subject to certain limitations
|
$
|
81,000
|
|
|
$
|
164,000
|
|
|
|
|
|
||||
Interest rates:
|
|
|
|
||||
LIBOR rate loans:
|
|
|
|
||||
Interest margin
|
2.00
|
%
|
|
2.00
|
%
|
||
Actual interest rates
|
3.25
|
%
|
|
2.81
|
%
|
October 1, 2017 through December 31, 2017
|
$
|
1,341
|
|
2018
|
4,757
|
|
|
2019
|
4,245
|
|
|
2020
|
3,829
|
|
|
2021
|
3,139
|
|
|
2022 and thereafter
|
8,727
|
|
|
Total minimum payments
|
$
|
26,038
|
|
|
|
Approval Date
|
December 2015
|
Authorized Repurchase Amount of Common Stock
|
$50 million
|
Effective Dates
|
December 2015 to December 2016
|
|
Accrual at June 30, 2017
|
|
Expense
|
|
Cash Payments
|
|
Accrual at September 30, 2017
|
|||||||
Severance and retention
|
$
|
853
|
|
|
$
|
676
|
|
|
(844
|
)
|
|
$
|
685
|
|
Professional fees
|
70
|
|
|
373
|
|
|
(179
|
)
|
|
264
|
|
|||
Total disposition related and other costs
|
$
|
923
|
|
|
$
|
1,049
|
|
|
(1,023
|
)
|
|
$
|
949
|
|
|
Accrual at December 31, 2016
|
|
Expense
|
|
Cash Payments
|
|
Accrual at September 30, 2017
|
|||||||
Severance and retention
|
$
|
—
|
|
|
$
|
1,793
|
|
|
(1,108
|
)
|
|
$
|
685
|
|
Professional fees
|
—
|
|
|
443
|
|
|
(179
|
)
|
|
264
|
|
|||
Total disposition related and other costs
|
$
|
—
|
|
|
$
|
2,236
|
|
|
(1,287
|
)
|
|
$
|
949
|
|
Severance
—
Slashdot Media
|
|
|
|
|
|
|
|
|
$
|
981
|
|
Accelerated stock based compensation expense
—
Slashdot Media
|
|
|
|
|
|
|
|
|
900
|
|
|
Loss on sale of Slashdot Media
|
|
|
|
|
|
|
|
|
639
|
|
|
Severance related to other brands
|
|
|
|
|
|
|
|
|
827
|
|
|
Total disposition related and other costs
|
|
|
|
|
|
|
|
|
$
|
3,347
|
|
|
Three Months Ended September 30, 2017
|
|
Three Months Ended September 30, 2016
|
||||||||||
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
||||||
Non-vested at beginning of the period
|
2,417,300
|
|
|
$
|
6.38
|
|
|
2,236,250
|
|
|
$
|
8.10
|
|
Granted
|
38,000
|
|
|
$
|
2.80
|
|
|
165,700
|
|
|
$
|
6.90
|
|
Forfeited
|
(183,375
|
)
|
|
$
|
6.71
|
|
|
(142,875
|
)
|
|
$
|
8.00
|
|
Vested
|
(35,125
|
)
|
|
$
|
8.93
|
|
|
(65,250
|
)
|
|
$
|
8.76
|
|
Non-vested at end of period
|
2,236,800
|
|
|
$
|
6.25
|
|
|
2,193,825
|
|
|
$
|
8.00
|
|
|
Nine Months Ended September 30, 2017
|
|
Nine Months Ended September 30, 2016
|
||||||||||
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
||||||
Non-vested at beginning of the period
|
2,226,375
|
|
|
$
|
7.87
|
|
|
2,122,225
|
|
|
$
|
8.54
|
|
Granted
|
1,262,500
|
|
|
$
|
4.72
|
|
|
1,199,200
|
|
|
$
|
7.47
|
|
Forfeited
|
(438,000
|
)
|
|
$
|
6.87
|
|
|
(294,375
|
)
|
|
$
|
8.15
|
|
Vested
|
(814,075
|
)
|
|
$
|
7.98
|
|
|
(833,225
|
)
|
|
$
|
8.57
|
|
Non-vested at end of period
|
2,236,800
|
|
|
$
|
6.25
|
|
|
2,193,825
|
|
|
$
|
8.00
|
|
|
|
Nine Months Ended September 30,
|
|
||||||
|
|
2017
|
|
2016
|
|
||||
Weighted average fair value of PSUs granted
|
|
$
|
5.38
|
|
|
$
|
7.24
|
|
|
Dividend yield of DHI Group, Inc. stock
|
|
—
|
%
|
|
—
|
%
|
|
||
Dividend yield of Russell 2000 Index
|
|
1.4
|
%
|
|
1.7
|
%
|
|
||
Risk free interest rate
|
|
1.5
|
%
|
|
0.9
|
%
|
|
||
Volatility of DHI Group, Inc. stock
|
|
41.0
|
%
|
|
33.5
|
%
|
|
||
Volatility of Russell 2000 Index
|
|
16.7
|
%
|
|
16.7
|
%
|
|
|
Three Months Ended September 30, 2017
|
|
Three Months Ended September 30, 2016
|
||||||||||
|
Shares
|
|
Weighted- Average Fair Value at
Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at
Grant Date
|
||||||
Non-vested at beginning of the period
|
890,838
|
|
|
$
|
6.92
|
|
|
670,838
|
|
|
$
|
8.03
|
|
Forfeited
|
(84,167
|
)
|
|
$
|
6.86
|
|
|
(72,084
|
)
|
|
$
|
8.05
|
|
Vested
|
—
|
|
|
$
|
—
|
|
|
(18,750
|
)
|
|
$
|
8.25
|
|
Non-vested at end of period
|
806,671
|
|
|
$
|
6.93
|
|
|
580,004
|
|
|
$
|
8.02
|
|
|
Nine Months Ended September 30, 2017
|
|
Nine Months Ended September 30, 2016
|
||||||||||
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
|
Shares
|
|
Weighted- Average Fair Value at Grant Date
|
||||||
Non-vested at beginning of the period
|
580,004
|
|
|
$
|
8.02
|
|
|
415,000
|
|
|
$
|
9.25
|
|
Granted
|
397,500
|
|
|
$
|
5.38
|
|
|
417,500
|
|
|
$
|
7.24
|
|
Forfeited
|
(170,833
|
)
|
|
$
|
7.04
|
|
|
(98,751
|
)
|
|
$
|
8.17
|
|
Vested
|
—
|
|
|
$
|
—
|
|
|
(153,745
|
)
|
|
$
|
9.13
|
|
Non-vested at end of period
|
806,671
|
|
|
$
|
6.93
|
|
|
580,004
|
|
|
$
|
8.02
|
|
|
Three Months Ended September 30, 2017
|
|||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
|||||
Options outstanding at beginning of the period
|
1,273,088
|
|
|
$
|
9.29
|
|
|
$
|
—
|
|
Forfeited
|
(136,875
|
)
|
|
$
|
9.42
|
|
|
$
|
—
|
|
Options outstanding at end of period
|
1,136,213
|
|
|
$
|
9.28
|
|
|
$
|
—
|
|
|
Three Months Ended September 30, 2016
|
|||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
|||||
Options outstanding at beginning of the period
|
2,273,323
|
|
|
$
|
7.89
|
|
|
$
|
539,367
|
|
Exercised
|
(336,360
|
)
|
|
$
|
4.86
|
|
|
$
|
854,271
|
|
Forfeited
|
(66,563
|
)
|
|
$
|
8.12
|
|
|
$
|
—
|
|
Options outstanding at end of period
|
1,870,400
|
|
|
$
|
8.43
|
|
|
$
|
1,059,282
|
|
|
Nine Months Ended September 30, 2017
|
|||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
|||||
Options outstanding at beginning of the period
|
1,779,613
|
|
|
$
|
8.46
|
|
|
$
|
50,869
|
|
Exercised
|
(66,188
|
)
|
|
$
|
6.08
|
|
|
$
|
12,821
|
|
Forfeited
|
(577,212
|
)
|
|
$
|
7.14
|
|
|
$
|
—
|
|
Options outstanding at end of period
|
1,136,213
|
|
|
$
|
9.28
|
|
|
$
|
—
|
|
Exercisable at end of period
|
1,086,743
|
|
|
$
|
9.36
|
|
|
$
|
—
|
|
|
Nine Months Ended September 30, 2016
|
|||||||||
|
Options
|
|
Weighted-Average Exercise Price
|
|
Aggregate Intrinsic Value
|
|||||
Options outstanding at beginning of the period
|
2,673,512
|
|
|
$
|
7.46
|
|
|
$
|
5,485,248
|
|
Exercised
|
(618,110
|
)
|
|
$
|
4.31
|
|
|
$
|
2,198,143
|
|
Forfeited
|
(185,002
|
)
|
|
$
|
8.16
|
|
|
$
|
—
|
|
Options outstanding at end of period
|
1,870,400
|
|
|
$
|
8.43
|
|
|
$
|
1,059,282
|
|
Exercisable at end of period
|
1,574,804
|
|
|
$
|
8.47
|
|
|
$
|
946,591
|
|
|
Options Outstanding
|
|
Options
Exercisable
|
||||
Exercise Price
|
Number
Outstanding
|
|
Weighted-
Average
Remaining
Contractual
Life
|
|
Number
Exercisable
|
||
|
|
|
(in years)
|
|
|
||
$ 7.00 - $ 7.99
|
327,375
|
|
|
3.4
|
|
285,687
|
|
$ 8.00 - $ 8.99
|
199,500
|
|
|
1.8
|
|
191,718
|
|
$ 9.00 - $ 9.99
|
480,000
|
|
|
2.6
|
|
480,000
|
|
$ 10.00 - $ 14.50
|
129,338
|
|
|
0.8
|
|
129,338
|
|
|
1,136,213
|
|
|
|
|
1,086,743
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
By Segment:
|
|
|
|
|
|
|
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Tech-focused
|
$
|
39,814
|
|
|
$
|
42,739
|
|
|
$
|
118,638
|
|
|
$
|
128,876
|
|
Healthcare
|
6,462
|
|
|
6,735
|
|
|
19,741
|
|
|
20,647
|
|
||||
Corporate & Other
|
6,148
|
|
|
6,599
|
|
|
18,635
|
|
|
22,509
|
|
||||
Total revenues
|
$
|
52,424
|
|
|
$
|
56,073
|
|
|
$
|
157,014
|
|
|
$
|
172,032
|
|
|
|
|
|
|
|
|
|
||||||||
Depreciation:
|
|
|
|
|
|
|
|
||||||||
Tech-focused
|
$
|
1,789
|
|
|
$
|
1,743
|
|
|
$
|
5,144
|
|
|
$
|
5,508
|
|
Healthcare
|
406
|
|
|
539
|
|
|
1,451
|
|
|
1,630
|
|
||||
Corporate & Other
|
381
|
|
|
196
|
|
|
1,108
|
|
|
501
|
|
||||
Total depreciation
|
$
|
2,576
|
|
|
$
|
2,478
|
|
|
$
|
7,703
|
|
|
$
|
7,639
|
|
|
|
|
|
|
|
|
|
||||||||
Amortization:
|
|
|
|
|
|
|
|
||||||||
Tech-focused
|
$
|
28
|
|
|
$
|
278
|
|
|
$
|
108
|
|
|
$
|
1,833
|
|
Healthcare
|
162
|
|
|
218
|
|
|
487
|
|
|
654
|
|
||||
Corporate & Other
|
364
|
|
|
1,074
|
|
|
1,091
|
|
|
3,619
|
|
||||
Total amortization
|
$
|
554
|
|
|
$
|
1,570
|
|
|
$
|
1,686
|
|
|
$
|
6,106
|
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss):
|
|
|
|
|
|
|
|
||||||||
Tech-focused
|
$
|
9,485
|
|
|
$
|
14,147
|
|
|
$
|
30,700
|
|
|
$
|
40,097
|
|
Healthcare
|
(187
|
)
|
|
(366
|
)
|
|
(1,279
|
)
|
|
(537
|
)
|
||||
Corporate & Other
|
(6,760
|
)
|
|
(29,864
|
)
|
|
(18,586
|
)
|
|
(44,516
|
)
|
||||
Operating income (loss)
|
2,538
|
|
|
(16,083
|
)
|
|
10,835
|
|
|
(4,956
|
)
|
||||
Interest expense
|
(1,173
|
)
|
|
(901
|
)
|
|
(2,777
|
)
|
|
(2,593
|
)
|
||||
Other expense
|
(3
|
)
|
|
(1
|
)
|
|
(10
|
)
|
|
(33
|
)
|
||||
Income (loss) before income taxes
|
$
|
1,362
|
|
|
$
|
(16,985
|
)
|
|
$
|
8,048
|
|
|
$
|
(7,582
|
)
|
|
|
|
|
|
|
|
|
||||||||
Capital expenditures:
|
|
|
|
|
|
|
|
||||||||
Tech-focused
|
$
|
1,931
|
|
|
$
|
1,783
|
|
|
$
|
7,544
|
|
|
$
|
5,595
|
|
Healthcare
|
366
|
|
|
245
|
|
|
996
|
|
|
642
|
|
||||
Corporate & Other
|
248
|
|
|
897
|
|
|
1,813
|
|
|
2,005
|
|
||||
Total capital expenditures
|
$
|
2,545
|
|
|
$
|
2,925
|
|
|
$
|
10,353
|
|
|
$
|
8,242
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
By Geography:
|
|
|
|
|
|
|
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
United States
|
$
|
38,869
|
|
|
$
|
41,617
|
|
|
$
|
117,026
|
|
|
$
|
126,617
|
|
United Kingdom
|
4,541
|
|
|
5,291
|
|
|
13,886
|
|
|
18,875
|
|
||||
EMEA, APAC and Canada (1)
|
9,014
|
|
|
9,165
|
|
|
26,102
|
|
|
26,540
|
|
||||
Non-United States
|
13,555
|
|
|
14,456
|
|
|
39,988
|
|
|
45,415
|
|
||||
Total revenues
|
$
|
52,424
|
|
|
$
|
56,073
|
|
|
$
|
157,014
|
|
|
$
|
172,032
|
|
|
|
|
|
|
|
|
|
||||||||
(1) Europe (excluding United Kingdom), the Middle East and Africa (“EMEA”) and Asia-Pacific (“APAC”)
|
|
September 30,
2017 |
|
December 31,
2016 |
||||
Total assets (recast for the change in reportable segments):
|
|
|
|
||||
Tech-focused
|
$
|
263,822
|
|
|
$
|
263,462
|
|
Healthcare
|
13,287
|
|
|
14,375
|
|
||
Corporate & Other
|
28,895
|
|
|
32,258
|
|
||
Total assets
|
$
|
306,004
|
|
|
$
|
310,095
|
|
|
Tech-focused
|
|
Healthcare
|
|
Corporate & Other
|
|
Total
|
||||||||
Goodwill at December 31, 2016
|
$
|
152,165
|
|
|
$
|
6,269
|
|
|
$
|
13,311
|
|
|
$
|
171,745
|
|
Foreign currency translation adjustment
|
$
|
4,896
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
4,896
|
|
Goodwill at September 30, 2017
|
$
|
157,061
|
|
|
$
|
6,269
|
|
|
$
|
13,311
|
|
|
$
|
176,641
|
|
|
Three Months Ended September 30,
|
|
Nine Months Ended September 30,
|
||||||||||||
|
2017
|
|
2016
|
|
2017
|
|
2016
|
||||||||
Net income
|
$
|
1,058
|
|
|
$
|
(16,841
|
)
|
|
$
|
4,220
|
|
|
$
|
(10,876
|
)
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average shares outstanding—basic
|
48,021
|
|
|
47,719
|
|
|
47,858
|
|
|
48,596
|
|
||||
Add shares issuable from stock-based awards
|
481
|
|
|
—
|
|
|
539
|
|
|
—
|
|
||||
Weighted-average shares outstanding—diluted
|
48,502
|
|
|
47,719
|
|
|
48,397
|
|
|
48,596
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Basic earnings per share
|
$
|
0.02
|
|
|
$
|
(0.35
|
)
|
|
$
|
0.09
|
|
|
$
|
(0.22
|
)
|
Diluted earnings per share
|
$
|
0.02
|
|
|
$
|
(0.35
|
)
|
|
$
|
0.09
|
|
|
$
|
(0.22
|
)
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
•
|
Tech-focused— Dice, Dice Europe, ClearanceJobs, eFinancialCareers, Brightmatter, (absorbed into Tech-focused in the third quarter of 2017), and excludes getTalent.
|
•
|
Healthcare— Health eCareers
|
|
Three Months Ended September 30,
|
|
Increase (Decrease)
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Tech-focused
|
$
|
39,814
|
|
|
$
|
42,739
|
|
|
$
|
(2,925
|
)
|
|
(6.8
|
)%
|
Healthcare
|
6,462
|
|
|
6,735
|
|
|
(273
|
)
|
|
(4.1
|
)%
|
|||
Corporate & Other
|
6,148
|
|
|
6,599
|
|
|
(451
|
)
|
|
(6.8
|
)%
|
|||
Total revenues
|
$
|
52,424
|
|
|
$
|
56,073
|
|
|
$
|
(3,649
|
)
|
|
(6.5
|
)%
|
|
Three Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Cost of revenues
|
$
|
7,616
|
|
|
$
|
7,943
|
|
|
$
|
(327
|
)
|
|
(4.1
|
)%
|
Percentage of revenues
|
14.5
|
%
|
|
14.2
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Product development
|
$
|
6,423
|
|
|
$
|
6,018
|
|
|
$
|
405
|
|
|
6.7
|
%
|
Percentage of revenues
|
12.3
|
%
|
|
10.7
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Sales and marketing
|
$
|
19,988
|
|
|
$
|
19,425
|
|
|
$
|
563
|
|
|
2.9
|
%
|
Percentage of revenues
|
38.1
|
%
|
|
34.6
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
General and administrative
|
$
|
9,454
|
|
|
$
|
10,101
|
|
|
$
|
(647
|
)
|
|
(6.4
|
)%
|
Percentage of revenues
|
18.0
|
%
|
|
18.0
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
(in thousands, except percentages)
|
||||||||||||||
Depreciation
|
$
|
2,576
|
|
|
$
|
2,478
|
|
|
$
|
98
|
|
|
4.0
|
%
|
Percentage of revenues
|
4.9
|
%
|
|
4.4
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Amortization
|
$
|
554
|
|
|
$
|
1,570
|
|
|
$
|
(1,016
|
)
|
|
(64.7
|
)%
|
Percentage of revenues
|
1.1
|
%
|
|
2.8
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
||||||||
2017
|
|
2016
|
|
||||||||||
(in thousands, except percentages)
|
|||||||||||||
Disposition related and other costs
|
$
|
1,049
|
|
|
$
|
—
|
|
|
$
|
1,049
|
|
|
n.m.
|
Percentage of revenues
|
2.0
|
%
|
|
—
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Interest expense
|
$
|
1,173
|
|
|
$
|
901
|
|
|
$
|
272
|
|
|
30.2
|
%
|
Percentage of revenues
|
2.2
|
%
|
|
1.6
|
%
|
|
|
|
|
|
Three Months Ended September 30,
|
||||||
2017
|
|
2016
|
|||||
(in thousands, except
percentages)
|
|||||||
Income (loss) before income taxes
|
$
|
1,362
|
|
|
$
|
(16,985
|
)
|
Income tax expense (benefit)
|
304
|
|
|
(144
|
)
|
||
Effective tax rate
|
22.3
|
%
|
|
0.8
|
%
|
|
Nine Months Ended September 30,
|
|
Increase (Decrease)
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Tech-focused
|
$
|
118,638
|
|
|
$
|
128,876
|
|
|
$
|
(10,238
|
)
|
|
(7.9
|
)%
|
Healthcare
|
19,741
|
|
|
20,647
|
|
|
$
|
(906
|
)
|
|
(4.4
|
)%
|
||
Corporate & Other
|
18,635
|
|
|
22,509
|
|
|
(3,874
|
)
|
|
(17.2
|
)%
|
|||
Total revenues
|
$
|
157,014
|
|
|
$
|
172,032
|
|
|
$
|
(15,018
|
)
|
|
(8.7
|
)%
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Cost of revenues
|
$
|
22,681
|
|
|
$
|
24,557
|
|
|
$
|
(1,876
|
)
|
|
(7.6
|
)%
|
Percentage of revenues
|
14.4
|
%
|
|
14.3
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Product development
|
$
|
19,230
|
|
|
$
|
19,323
|
|
|
$
|
(93
|
)
|
|
(0.5
|
)%
|
Percentage of revenues
|
12.2
|
%
|
|
11.2
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Sales and marketing
|
$
|
59,638
|
|
|
$
|
58,573
|
|
|
$
|
1,065
|
|
|
1.8
|
%
|
Percentage of revenues
|
38.0
|
%
|
|
34.0
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
General and administrative
|
$
|
30,779
|
|
|
$
|
32,822
|
|
|
$
|
(2,043
|
)
|
|
(6.2
|
)%
|
Percentage of revenues
|
19.6
|
%
|
|
19.1
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
(in thousands, except percentages)
|
||||||||||||||
Depreciation
|
$
|
7,703
|
|
|
$
|
7,639
|
|
|
$
|
64
|
|
|
0.8
|
%
|
Percentage of revenues
|
4.9
|
%
|
|
4.4
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
|
(in thousands, except percentages)
|
|||||||||||||
Amortization
|
$
|
1,686
|
|
|
$
|
6,106
|
|
|
$
|
(4,420
|
)
|
|
(72.4
|
)%
|
Percentage of revenues
|
1.1
|
%
|
|
3.5
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Decrease
|
|
Percent
Change
|
|||||||||
2017
|
|
2016
|
|
|||||||||||
(in thousands, except percentages)
|
||||||||||||||
Disposition related and other costs
|
$
|
2,236
|
|
|
$
|
3,347
|
|
|
$
|
(1,111
|
)
|
|
(33.2
|
)%
|
Percentage of revenues
|
1.4
|
%
|
|
1.9
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
Increase
|
|
Percent
Change
|
||||||||
2017
|
|
2016
|
|
||||||||||
|
(in thousands, except percentages)
|
||||||||||||
Interest expense
|
2,777
|
|
|
$
|
2,593
|
|
|
$
|
184
|
|
|
7.1
|
%
|
Percentage of revenues
|
1.8
|
%
|
|
1.5
|
%
|
|
|
|
|
|
Nine Months Ended September 30,
|
||||||
2017
|
|
2016
|
|||||
(in thousands, except
percentages)
|
|||||||
Income (loss) before income taxes
|
$
|
8,048
|
|
|
$
|
(7,582
|
)
|
Income tax expense
|
3,828
|
|
|
3,294
|
|
||
Effective tax rate
|
47.6
|
%
|
|
(43.4
|
)%
|
•
|
Adjusted EBITDA does not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments;
|
•
|
Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
|
•
|
Adjusted EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on your debt;
|
•
|
Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized often will have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements; and
|
•
|
Other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.
|
|
For the nine months ended September 30,
|
||||||
2017
|
|
2016
|
|||||
Reconciliation of Net Income to Adjusted EBITDA:
|
|
|
|
||||
Net income
|
$
|
4,220
|
|
|
$
|
(10,876
|
)
|
Interest expense
|
2,777
|
|
|
2,593
|
|
||
Income tax expense
|
3,828
|
|
|
3,294
|
|
||
Depreciation
|
7,703
|
|
|
7,639
|
|
||
Amortization of intangible assets
|
1,686
|
|
|
6,106
|
|
||
Impairment of goodwill
|
—
|
|
|
15,369
|
|
||
Non-cash stock compensation expense
|
6,275
|
|
|
7,850
|
|
||
Impairment of fixed and intangible assets
|
2,226
|
|
|
9,252
|
|
||
Severance--Slashdot Media
|
—
|
|
|
981
|
|
||
Accelerated stock based compensation expense--Slashdot Media
|
—
|
|
|
900
|
|
||
Loss on sale of business
|
—
|
|
|
639
|
|
||
Costs related to strategic alternatives process
|
807
|
|
|
—
|
|
||
Costs related to divestitures
|
442
|
|
|
—
|
|
||
Other
|
10
|
|
|
33
|
|
||
Adjusted EBITDA
|
$
|
29,974
|
|
|
$
|
43,780
|
|
|
|
|
|
||||
Reconciliation of Operating Cash Flows to Adjusted EBITDA:
|
|
|
|
||||
Net cash provided by operating activities
|
$
|
27,179
|
|
|
$
|
37,012
|
|
Interest expense
|
2,777
|
|
|
2,593
|
|
||
Amortization of deferred financing costs
|
(642
|
)
|
|
(243
|
)
|
||
Income tax expense
|
3,828
|
|
|
3,294
|
|
||
Deferred income taxes
|
23
|
|
|
1,977
|
|
||
Severance--Slashdot Media
|
—
|
|
|
981
|
|
||
Change in accrual for unrecognized tax benefits
|
(2,358
|
)
|
|
(166
|
)
|
||
Change in accounts receivable
|
(10,607
|
)
|
|
(8,047
|
)
|
||
Change in deferred revenue
|
3,774
|
|
|
493
|
|
||
Costs related to strategic alternatives process
|
807
|
|
|
—
|
|
||
Costs related to divestitures
|
442
|
|
|
—
|
|
||
Changes in working capital and other
|
4,751
|
|
|
5,886
|
|
||
Adjusted EBITDA
|
$
|
29,974
|
|
|
$
|
43,780
|
|
|
For the nine months ended September 30,
|
||||||
2017
|
|
2016
|
|||||
Cash from operating activities
|
$
|
27,179
|
|
|
$
|
37,012
|
|
Cash used in investing activities
|
(10,660
|
)
|
|
(6,032
|
)
|
||
Cash used in financing activities
|
(17,722
|
)
|
|
(35,294
|
)
|
|
Payments due by period
|
||||||||||||||||||
Total
|
|
Less Than 1 Year
|
|
2-3 Years
|
|
4-5 Years
|
|
More Than 5 Years
|
|||||||||||
|
(in thousands)
|
||||||||||||||||||
Credit Agreement
|
$
|
69,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
69,000
|
|
|
$
|
—
|
|
Operating lease obligations
|
26,038
|
|
|
1,341
|
|
|
9,002
|
|
|
6,968
|
|
|
8,727
|
|
|||||
Total contractual obligations
|
$
|
95,038
|
|
|
$
|
1,341
|
|
|
$
|
9,002
|
|
|
$
|
75,968
|
|
|
$
|
8,727
|
|
Item 3.
|
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4.
|
Controls and Procedures
|
Item 1.
|
Legal Proceedings
|
Item 1A.
|
Risk Factors
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
10.1*
|
|
|
31.1*
|
|
|
31.2*
|
|
|
32.1*
|
|
|
32.2*
|
|
|
101.INS
|
|
XBRL Instance Document.
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
*
|
|
Filed herewith.
|
Date:
|
November 2, 2017
|
|
DHI Group, Inc.
|
|
|
|
|
Registrant
|
|
|
|
|
|
|
|
|
|
By:
|
/S/ Michael P. Durney
|
|
|
|
|
Michael P. Durney
President and Chief Executive Officer
|
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/S/ Luc Grégoire
|
|
|
|
|
Luc Grégoire
Chief Financial Officer
|
|
|
|
|
(Principal Financial Officer)
|
10.1*
|
|
Consent Memorandum, dated August 15, 2017, among JPMorgan Chase Bank, N.A, as administrative agent (the "Administrative Agent"), the Lenders party thereto, and DHI Group, Inc., Dice Inc., and Dice Career Solutions, Inc., as borrowers (the “Borrowers”), related to that certain Amended and Restated Credit Agreement, dated as of November 24, 2015 (as amended) by and among the Borrowers, the Lenders party thereto and the Administrative Agent.
|
31.1*
|
|
Certifications of Michael Durney, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
31.2*
|
|
Certifications of Luc Grégoire, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
32.1*
|
|
Certifications of Michael Durney, Chief Executive Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
32.2*
|
|
Certifications of Luc Grégoire, Chief Financial Officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
101.INS
|
|
XBRL Instance Document.
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document.
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
*
|
|
Filed herewith.
|
1 Year DHI Chart |
1 Month DHI Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions